G5610A

# **General Information**

| **Position** | **5610** | **Variant** | **m.5610G\>A** | **Locus** | **MT\-TA** | **RNA** | **tRNA Ala** |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Homoplasmy** | \- | **Heteroplasmy** | \+ | **mitoTIP** | 38\.70% | **Pathogenicity** | Reported \[VUS] |

"Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/).

# **Pedigree Information**

The **m.5610G\>A** variant in MT\-TA has been reported in 1 pedigree. To date, 1 carrier has been reported. Reported mutation loads ranged from 87% to 91%, with a median of 89% overall; affected carriers showed mutation loads from 87% to 91%, with a median of 89%. The main clinical manifestations among affected carriers included progressive weakness, limb girdle muscles, and proximal paresis.

| **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | 5610 | m.5610G\>A | G5610A\-F1 | Germany | Pure mitochondrial myopathy | 10 | 0 | 2015 | [25873012](https://pubmed.ncbi.nlm.nih.gov/25873012/) |  |

# **Carrier Information**

| **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | 5610 | m.5610G\>A | G5610A\-F1 | G5610A\-F1\-I2 | Uninf | F | Y | Y | A | 69 | 87% | 91% | / | / | Progressive weakness, limb girdle muscles, proximal paresis |  |

For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).